BENFARI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 5.178
EU - Europa 5.074
AS - Asia 3.450
SA - Sud America 440
Continente sconosciuto - Info sul continente non disponibili 215
AF - Africa 124
OC - Oceania 13
Totale 14.494
Nazione #
US - Stati Uniti d'America 5.068
RU - Federazione Russa 2.136
SG - Singapore 1.408
GB - Regno Unito 930
CN - Cina 900
IT - Italia 576
BR - Brasile 333
HK - Hong Kong 317
VN - Vietnam 297
DE - Germania 270
IE - Irlanda 265
FR - Francia 261
SE - Svezia 237
FI - Finlandia 131
KR - Corea 120
BD - Bangladesh 94
IN - India 72
CA - Canada 65
UA - Ucraina 48
PL - Polonia 42
NL - Olanda 41
AR - Argentina 40
JP - Giappone 34
ID - Indonesia 30
ZA - Sudafrica 30
TR - Turchia 28
AT - Austria 26
ES - Italia 23
EG - Egitto 22
PK - Pakistan 22
MX - Messico 20
EC - Ecuador 19
BE - Belgio 17
SA - Arabia Saudita 16
VE - Venezuela 16
IQ - Iraq 15
TG - Togo 14
NG - Nigeria 13
CZ - Repubblica Ceca 12
IR - Iran 12
CO - Colombia 11
AU - Australia 10
BJ - Benin 9
LT - Lituania 9
AZ - Azerbaigian 8
MA - Marocco 8
CH - Svizzera 7
PH - Filippine 7
RO - Romania 7
UZ - Uzbekistan 7
DZ - Algeria 6
GR - Grecia 6
IL - Israele 6
PE - Perù 6
TN - Tunisia 6
TW - Taiwan 6
JM - Giamaica 5
MY - Malesia 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CR - Costa Rica 4
JO - Giordania 4
PT - Portogallo 4
PY - Paraguay 4
CI - Costa d'Avorio 3
CL - Cile 3
ET - Etiopia 3
GE - Georgia 3
HR - Croazia 3
KE - Kenya 3
KG - Kirghizistan 3
LV - Lettonia 3
NI - Nicaragua 3
NP - Nepal 3
PA - Panama 3
SI - Slovenia 3
TH - Thailandia 3
A1 - Anonimo 2
AF - Afghanistan, Repubblica islamica di 2
AM - Armenia 2
AO - Angola 2
BG - Bulgaria 2
BO - Bolivia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
HU - Ungheria 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
Totale 14.262
Città #
Southend 806
Moscow 769
Singapore 714
Ashburn 709
Chandler 616
San Jose 567
Dallas 424
Hong Kong 314
Council Bluffs 280
Dublin 244
Verona 190
Beijing 183
The Dalles 163
Jacksonville 132
New York 132
Ho Chi Minh City 112
Los Angeles 108
Munich 92
Lawrence 87
Princeton 87
Woodbridge 82
Hanoi 76
Wilmington 73
Helsinki 68
Redondo Beach 51
Santa Clara 50
Ann Arbor 48
Shenyang 48
Columbus 47
Houston 47
Sindelfingen 47
Milan 46
Jinan 45
São Paulo 39
Washington 37
Buffalo 35
Turku 34
Seattle 32
Nanjing 30
London 29
Warsaw 27
Orem 26
Guangzhou 25
Montreal 25
Tokyo 25
Frankfurt am Main 24
Hebei 24
Stockholm 24
Denver 21
Johannesburg 21
Brooklyn 20
Phoenix 20
Redwood City 20
Tianjin 20
Atlanta 19
Amsterdam 18
Hangzhou 18
Bologna 17
Jiaxing 17
Lancaster 17
Nuremberg 17
Zhengzhou 17
Brussels 16
Chennai 16
Haikou 16
Norwalk 16
Rio de Janeiro 16
Rome 16
Chicago 15
San Francisco 15
Changsha 14
Da Nang 14
Lappeenranta 14
Lomé 14
Nanchang 14
Kent 13
Manchester 13
Ningbo 13
Seoul 13
Boston 12
Falkenstein 12
Jakarta 12
Abuja 11
New Delhi 11
Riyadh 11
Taizhou 11
Alexandria 10
Fairfield 10
Haiphong 10
Mexico City 10
Naples 10
Olomouc 10
Toronto 10
Cotonou 9
Karachi 9
Paris 9
Taiyuan 9
Belo Horizonte 8
Dhaka 8
Dongguan 8
Totale 8.613
Nome #
Mitral Regurgitation and Increased Risk of All-Cause and Cardiovascular Mortality in Patients with Type 2 Diabetes 654
Correction: SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 232
Atrial Function as an Independent Predictor of Postoperative Atrial Fibrillation in Patients Undergoing Aortic Valve Surgery for Severe Aortic Stenosis 217
Effects of Aortic Valve Replacement on Left Ventricular Diastolic Function in Patients With Aortic Valve Stenosis 195
Left ventricular end-diastolic volume as early indicator of trastuzumab-related cardiotoxicity in HER2+ breast cancer patients: results from a single-center retrospective study 195
Left atrial volume in patients with HER2-positive breast cancer: One step further to predict trastuzumab-related cardiotoxicity 190
Clinical Implications of Distal Vessel Stenosis After Successful Coronary Chronic Total Occlusion Recanalization 187
Drug-coated balloon: Long-term outcome from a real world three-center experience 187
Clinical impact of mitral regurgitation in aortic valve stenosis: Insight from effective regurgitant orifice area 180
Usefulness of Left Atrial Remodeling in Predicting CardiacToxicity During Trastuzumab Therapy for Breast Cancer 179
A New Method to Evaluate Atrial Hemodynamic and Quantify Mitral Regurgitation using Cardiovascular Magnetic Resonance: The Pulmonary Venous Flow Approach 178
Comparative Prognostic Value of Parameters of Pulsatile Right Ventricular Afterload in Patients With Advanced Heart Failure Awaiting Heart Transplantation 177
A higher body mass index is associated with reduced prevalence of unstable atherosclerotic plaque: A possible explanation of the obesity paradox. 175
Drug eluting balloon for the treatment of patients with coronary artery disease: Current perspectives 175
The Common Combination of Aortic Stenosis with Mitral Regurgitation: Diagnostic Insight and Therapeutic Implications in the Modern Era of Advanced Echocardiography and Percutaneous Intervention 174
Mitral Effective Regurgitant Orifice Area Predicts Pulmonary Artery Pressure Level in Patients with Aortic Valve Stenosis 170
Determinants of exercise intolerance symptoms considered non-specific for heart failure in patients with stage A and B: role of the left atrium in the transition phase to overt heart failure 169
Optimizing the role of transthoracic echocardiography to improve the cardiovascular risk stratification: the dream of subclinical coronary artery disease detection 167
Feasibility, Reproducibility and Reference Ranges of Left Atrial Strain in Preterm and Term Neonates in the First 48 h of Life 166
The Activated Clotting Time Paradox: Relationship Between Activated Clotting Time and Occlusion of the Radial Artery When Used as Vascular Access for Percutaneous Coronary Procedures 165
The progression rate of aortic stenosis: key to tailoring the management and potential target for treatment 165
iFR-FFR comparison in daily practice: a single-center, prospective, online assessment 164
Acute electrocardiographic differences between Takotsubo cardiomyopathy and anterior ST elevation myocardial infarction 163
Echocardiographically Derived Pulse Wave Velocity and Diastolic Dysfunction Are Associated with an Increased Incidence of Atrial Fibrillation in Patients with Systolic Heart Failure 161
Concomitant mitral regurgitation and aortic stenosis: one step further to low-flow preserved ejection fraction aortic stenosis 161
Tpeak-to-Tend/QT is an independent predictor of early ventricular arrhythmias and arrhythmic death in anterior ST elevation myocardial infarction patients 160
Excess mortality associated with progression rate in asymptomatic aortic valve stenosis 157
Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis 155
Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation 154
Role of Speckle Tracking Echocardiography in the Evaluation of Breast Cancer Patients Undergoing Chemotherapy: Review and Meta-analysis of the Literature 154
Functional mitral regurgitation: are we treating the real target? 153
Quadricuspid mitral valve: Of clefts, scallops, and indentations 150
Characterisation of coronary microvascular dysfunction in patients with severe aortic stenosis undergoing TAVI 149
Mitral regurgitation and dyspnoea: The expanding role of mitral effective regurgitant orifice among un-selected patients 149
Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome 148
Correlation between epicardial adipose tissue and atrial fibrillation burden in coronary artery bypass graft surgery 147
Takotsubo syndrome: a neurocardiac syndrome inside the autonomic nervous system 146
Basic and advanced echocardiography in advanced heart failure: an overview 145
Discrepancies in Assessing Diastolic Function in Pre-Clinical Heart Failure Using Different Algorithms—A Primary Care Study 145
Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Supraventricular and Ventricular Tachyarrhythmias in Patients with Type 2 Diabetes 144
Clinical outcome of degenerative mitral regurgitation critical importance of echocardiographic quantitative assessment in routine practice 142
How to incorporate left atrial strain in the diagnostic algorithm of left ventricular diastolic dysfunction 142
Resolving the Conundrum of Functional Mitral Regurgitation in Heart Failure with reduced Ejection Fraction. 139
Bedside Ultrasound for Hemodynamic Monitoring in Cardiac Intensive Care Unit 137
Bicuspid Aortic Valve Disease from Infancy to Older Age: A 25-Year Experience from an Italian Referral Center 137
Functional mitral regurgitation in patients with aortic stenosis: prevalence, clinical correlates and pathophysiological determinants: a quantitative prospective study. 137
Relevance of Functional Mitral Regurgitation in Aortic Valve Stenosis 137
Echocardiographic Strain Imaging in Coronary Artery Disease: The Added Value of a Quantitative Approach 137
Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis 137
Is TAVI superior to surgery in high-risk patients? Insight into the concept of individual risk assessment 132
Clinical presentation and outcome of tricuspid regurgitation in patients with systolic dysfunction 129
Mitral regurgitation, left atrial structural and functional remodelling and the effect on pulmonary haemodynamics 129
Global longitudinal strain is an informative index of left ventricular performance in neonates receiving intensive care 128
Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future 128
Detection of cardiac allograft vasculopathy by multi-layer left ventricular longitudinal strain in heart transplant recipients 128
Dynamic changes of repolarization abnormalities in takotsubo cardiomyopathy 124
The Central Role of Left Atrium in Heart Failure 124
Aortic root/left ventricular diameters golden ratio in competitive athletes 124
Radial artery occlusion after transradial procedures: impact on 1-year adverse events 123
Feasibility and relevance of right parasternal view for assessing severity and rate of progression of aortic valve stenosis in primary care 123
Left Atrial Volumetric/Mechanical Coupling Index: A Novel Predictor of Outcome in Heart Failure With Reduced Ejection Fraction 123
Pathophysiology of Degenerative Mitral Regurgitation: New 3-Dimensional Imaging Insights 122
Degree of left ventricular dilatation at end-diastole: Correlation and prognostic utility of quantitative volumes by 2D-echocardiography versus linear dimensions in patients with asymptomatic aortic regurgitation 121
RANKL Expression Is Increased in Circulating Mononuclear Cells of Patients with Calcific Aortic Stenosis 119
Efficacy of Coronary Sinus Reducer in Patients With Non-revascularized Chronic Total Occlusions 119
Unequivocal interpretation of dobutamine stress echocardiography in low‐flow, low‐gradient aortic stenosis by right parasternal view 119
Tissue-Tracking Mitral Annular Displacement in Neonates: A Novel Index of Left Ventricular Systolic Function 117
Prevalence of patients with severely reduced aortic valve area and low gradient despite a preserved ejection fraction. Results from a cath-lab data base. 116
Novel Approaches in Cardiac Imaging for Non-invasive Assessment of Left Heart Myocardial Fibrosis 113
Role of eccentric cycling in older adults affected by sarcopenia and heart failure: a feasibility and efficacy study protocol 113
Bicuspid aortic valve and sports: From the echocardiographic evaluation to the eligibility for sports competition 110
Myocardial fibrosis and steatosis in patients with aortic stenosis: roles of myostatin and ceramides 107
Right Ventricle Pulmonary Artery Coupling and Renal Function in Patients With Severe Aortic Stenosis Undergoing TAVR 106
Stress Echo 2030: The Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging 105
Transcatheter Versus Medical Treatment of Patients With Symptomatic Severe Tricuspid Regurgitation 105
Functional Mitral Regurgitation Outcome and Grading in Heart~Failure With Reduced Ejection Fraction 104
Contemporary differences between bicuspid and tricuspid aortic valve in chronic aortic regurgitation 102
Right Atrial Function Role in Tricuspid Regurgitation-Related Systemic Venous Congestion 101
Left atrial dilatation in systolic heart failure: a marker of poor prognosis, not just a buffer between the left ventricle and pulmonary circulation 101
Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week 101
Impaired myocardial work efficiency in heart failure with preserved ejection fraction 99
Mitral Valve Prolapse Patients with Less than Moderate Mitral Regurgitation Exhibit Early Cardiac Chamber Remodeling 98
Multicentric Atrial Strain {COmparison} between Two Different Modalities: {MASCOT} {HIT} Study 98
Left atrial strain by speckle tracking predicts atrial fibrosis in patients undergoing heart transplantation 98
Heart valve calcification and cardiac hemodynamics 96
The right parasternal window: when Doppler-beam alignment may be life-saving in patients with aortic valve stenosis 96
Outcome of consistent guideline-based tricuspid management in patients undergoing degenerative mitral regurgitation correction 96
Myocardial Work by Echocardiography: Principles and Applications in Clinical Practice 96
Tricuspid regurgitation is a public health crisis 94
Presentation and Outcome of Arrhythmic Mitral Valve Prolapse 93
Functional Mitral Regurgitation: A proportionate or disproportionate focus of attention? 92
Diastolic Determinants of Excess Mortality in Heart Failure With Reduced Ejection Fraction 88
Functional tricuspid regurgitation of degenerative mitral valve disease: a crucial determinant of survival 86
Transcatheter edge-to-edge mitral valve repair: what is the measure of success? 84
Imaging Quality Control, Methodology Harmonization and Clinical Data Management in Stress Echo 2030 80
Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation 79
Ischemic Mitral Regurgitation: A Multifaceted Syndrome with Evolving Therapies 76
Excess Mortality Associated with Functional Tricuspid Regurgitation Complicating Heart Failure with Reduced Ejection Fraction 75
Prognostic Implications of Left Atrial Enlargement in Degenerative Mitral Regurgitation 72
Factors influencing post-surgical survival in degenerative mitral regurgitation 71
Totale 13.830
Categoria #
all - tutte 60.306
article - articoli 59.840
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 466
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.612


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022429 0 0 27 29 56 12 13 31 25 31 46 159
2022/20231.682 101 197 165 271 135 385 30 115 201 15 54 13
2023/2024938 25 77 70 114 98 165 61 87 10 47 147 37
2024/20252.320 112 115 66 381 138 88 85 126 352 180 236 441
2025/20266.767 480 300 467 1.045 1.772 434 523 377 558 391 172 248
2026/2027509 97 279 133 0 0 0 0 0 0 0 0 0
Totale 14.494